Fu J, Zheng X, Ma X, Qu Q, et al. Clinical outcomes, serum IgG changes, and follow-up observations in the treatment of anti-AChR antibody-positive generalized myasthenia gravis with Efgartigimod. BMC Neurol 2026 Feb 16. doi: 10.1186/s12883-026-04726.
PMID: 41699526